SCHEMBL245327

SCHEMBL245327

CC(C)(C)OC(=O)NCC(C)(O)c1cccc(Br)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSB P07858 1/20 0.45
CTSS P25774 1/20 0.45
CTSK P43235 1/20 0.45
AAK1 Q2M2I8 8/20 0.41
EGFR P00533 1/20 0.41
RAF1 P04049 1/20 0.41
KDR P35968 1/20 0.41
MAP2K2 P36507 1/20 0.41
MAP2K1 Q02750 1/20 0.41
AURKB Q96GD4 1/20 0.41
KDM4A O75164 1/20 0.40
NQO2 P16083 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TP53BP1 Q12888 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
FPR3 P25089 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3987101 0.88 CTSB (0.46) CTSBCTSSCTSKAAK1EGFR
SCHEMBL28294256 0.85 CTSB (0.47) CTSBCTSSCTSKAAK1EGFR
SCHEMBL246563 0.84 CTSB (0.43) CTSBCTSSCTSKAAK1EGFR
SCHEMBL12496748 0.83 MEN1 (0.41) SMN1; SMN2MEN1KMT2ATP53BP1L3MBTL1
SCHEMBL245178 0.80 SMN1; SMN2 (0.52) SMN1; SMN2MEN1KMT2AL3MBTL1NPC1
SCHEMBL1257719 0.80 L3MBTL1 (0.41) SMN1; SMN2MEN1KMT2ATP53BP1L3MBTL1
SCHEMBL1822759 0.79 CA1 (0.40) KDM4ANQO2CA1CA2L3MBTL1
SCHEMBL2754681 0.77 CTSB (0.52) CTSBCTSSCTSKAAK1EGFR
SCHEMBL2580865 0.77 AAK1 (0.45) CTSBCTSSCTSKAAK1SMN1; SMN2
SCHEMBL6968045 0.77 KDM4A (0.38) AAK1KDM4ANQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655376-A1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) Janssen Pharmaceutica NV (BE) 2013-10-30 EP disclosed
EP-2619207-A1 4,7-DIHYDRO-PYRAZOLO[1,5-a]PYRAZIN-6-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) Janssen Pharmaceutica, N.V. (BE) 2013-07-31 EP disclosed
EP-2585440-A1 3-AMINO-5,6-DIHYDRO-1H-PYRAZIN-2-ONE DERIVATIVES USEFUL FOR THE TREATEMENT OF ALZHEIMER'S DISEASE AND OTHER FORMS OF DEMENTIA Janssen Pharmaceutica, N.V. (BE) 2013-05-01 EP disclosed
WO-2012085038-A1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) JANSSEN PHARMACEUTICA NV (BE) 2012-06-28 WO disclosed
WO-2012038438-A1 4,7-DIHYDRO-PYRAZOLO[1,5-a]PYRAZIN-6-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) JANSSEN PHARMACEUTICA NV (BE) 2012-03-29 WO disclosed
WO-2012000933-A1 3-AMINO-5,6-DIHYDRO-1H-PYRAZIN-2-ONE DERIVATIVES USEFUL FOR THE TREATEMENT OF ALZHEIMER'S DISEASE AND OTHER FORMS OF DEMENTIA JANSSEN PHARMACEUTICA NV (BE) 2012-01-05 WO disclosed